date,title,source
Oct-24-18,"New Research: Key Drivers of Growth for Workhorse Group, Fate Therapeutics, Minerals Technologies, Tyson Foods, ZAGG, and USA Technologies  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Oct-25-18,3 Healthcare Stocks To Watch On Thursday,ACCESSWIRE
Oct-29-18,Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2018 Financial Results,GlobeNewswire
Nov-01-18,"Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-01-18,Fate Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Fate Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Operational Progress,GlobeNewswire
Nov-01-18,Fate Therapeutics Announces Seven Presentations at the 2018 ASH Annual Meeting,GlobeNewswire
Nov-07-18,Edited Transcript of FATE earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Nov-08-18,Fate Therapeutics to Present at Upcoming Investor Conferences,GlobeNewswire
Nov-16-18,What Kind Of Shareholder Appears On The Fate Therapeutics Incs (NASDAQ:FATE) Shareholder Register?,Simply Wall St.
Nov-28-18,3 Themes To Watch As Biopharmas 'Bring Some Excitement' In Blood Cancer,Investor's Business Daily
Nov-30-18,How Healthcare Is Evolving & Sector Stocks To Watch,ACCESSWIRE
Nov-30-18,Shares of Fate Therapeutics up 4.1% in premarket trade after FDA accepts IND application for potential cancer treatment,MarketWatch
Nov-30-18,"Fate Therapeutics Announces FDA Clearance of Landmark IND for FT500 iPSC-derived, Off-the-Shelf NK Cell Cancer Immunotherapy",GlobeNewswire
Dec-03-18,Fate Therapeutics Secures Exclusive Option to Novel Humanized anti-BCMA CAR Constructs for Development of iPSC-derived Cell Products,GlobeNewswire
Dec-03-18,Fate Therapeutics (FATE) Jumps: Stock Rises 8.9%,Zacks
Dec-03-18,"Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences  Discovering Underlying Factors of Influence",GlobeNewswire
Dec-19-18,Fate Therapeutics Inc (FATE) Hedge Funds Are Snapping Up,Insider Monkey
Jan-22-19,"Why Fate Therapeutics, Inc.s (NASDAQ:FATE) CEO Pay Matters To You",Simply Wall St.
Feb-06-19,Fate Therapeutics stock up 11% after FDA clears IND application,MarketWatch
Feb-06-19,Fate Therapeutics Announces FDA Clearance of IND Application for Worlds First Cell Therapy Derived from an Engineered Pluripotent Stem Cell,GlobeNewswire
Feb-07-19,Fate Therapeutics to Present at Guggenheim Healthcare Talks Idea Forum Oncology Day,GlobeNewswire
Feb-20-19,"Fate Therapeutics Appoints Sarah Cooley, M.D., M.S. as Senior Vice President, Clinical Translation",GlobeNewswire
Feb-22-19,Fate Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Feb-25-19,Fate Therapeutics (FATE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Zacks
Feb-25-19,"Market Trends Toward New Normal in Nuance Communications, Fate Therapeutics, Hamilton Lane, InflaRx N.V, Enerplus, and ManTech International  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Feb-28-19,Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Feb-28-19,Cronos (CRON) to Report Q4 Earnings: What's in the Cards?,Zacks
Mar-05-19,Fate Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress,GlobeNewswire
Mar-05-19,"Fate Therapeutics, Inc. to Host Earnings Call",ACCESSWIRE
Mar-06-19,Fate Therapeutics Inc (FATE) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-06-19,Edited Transcript of FATE earnings conference call or presentation 5-Mar-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-07-19,Edited Transcript of FATE earnings conference call or presentation 5-Mar-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-11-19,Edited Transcript of FATE earnings conference call or presentation 5-Mar-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-18-19,"Fate Therapeutics Announces the Appointment of Karin Jooss, Ph.D. to its Board of Directors",GlobeNewswire
Mar-26-19,"What Do Analysts Think About Fate Therapeutics, Inc.s (NASDAQ:FATE) Earnings Trajectory?",Simply Wall St.
Apr-01-19,Fate Therapeutics Presents Late-Breaking Preclinical Data Highlighting Unique Advantages of Clonal Master Engineered iPSC Lines for Off-the-Shelf CAR T-cell Therapy at 2019 AACR Annual Meeting,GlobeNewswire
Apr-02-19,Fate Therapeutics Announces First Patient Treated with iPSC-derived NK Cell Cancer Immunotherapy FT500 Successfully Completes Initial Safety Assessment,GlobeNewswire
Apr-18-19,"Fate Therapeutics Appoints Wayne Chu, M.D. as Vice President, Clinical Development",GlobeNewswire
Apr-24-19,Fate Therapeutics Announces Five Presentations at the American Society of Gene & Cell Therapy 22nd Annual Meeting,GlobeNewswire
Apr-30-19,Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2019 Financial Results,GlobeNewswire
May-03-19,Is Fate Therapeutics Inc (FATE) A Good Stock To Buy?,Insider Monkey
May-07-19,"Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue Estimates",Zacks
May-07-19,Fate Therapeutics: 1Q Earnings Snapshot,Associated Press
May-07-19,Fate Therapeutics Reports First Quarter 2019 Financial Results and Highlights Operational Progress,GlobeNewswire
